VIEW PRESS RELEASE [PDF] April 5, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published…
Blog Archives
PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with…
PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment…
Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease
A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93
PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders
VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential…
Tagged with: baylor college of medicine, essential tremor, et, funding, kinesia, nih, parkinson's disease, rush university medical center, sbir, tremor
PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD…
PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study
VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment…
Logarithmic Relationship Between Head Tremor and 5-Point Tremor Rating
Rodger Elble, MD PhD, Helge Hellriegel, MD, Jan Raethjen, MD and Günther Deuschl, MD International Congress Of Parkinson’s Disease And Movement Disorders, Toronto, CA 2011
PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude)…
Tagged with: ama, category iii cpt, efficacy, evaluation, kinesia, motor sumptom, movement disorder, symptom severity, telemedicine, tremor, wireless
Clinically Deployable Kinesia Technology for Automated Tremor Assessment
J. Giuffrida, D. Riley, B. Maddux, D. Heldman Mov Disord. 2009 Apr 15;24(5):723-30